These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7102503)

  • 21. Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure.
    MacMahon B; Bakshi M; Branagan P; Kelly JG; Walsh MJ
    Br J Clin Pharmacol; 1985 Apr; 19(4):429-34. PubMed ID: 3922392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability of early lidocaine levels in patients.
    Zito RA; Reid PR; Longstreth JA
    Am Heart J; 1977 Sep; 94(3):292-6. PubMed ID: 888762
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of heart failure, liver disease, and renal failure on the disposition of lidocaine in man.
    Thomson PD; Rowland M; Melmon KL
    Am Heart J; 1971 Sep; 82(3):417-21. PubMed ID: 5565429
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass.
    Autschbach R; Falk V; Lange H; Oellerich M; Walther T; Mohr FW; Dalichau H
    Thorac Cardiovasc Surg; 1996 Apr; 44(2):76-80. PubMed ID: 8782332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lidocaine plasma concentrations following administration of intraoral lidocaine solution.
    Greenblatt DJ; Benjamin DM; Willis CR; Harmatz JS; Zinny MA
    Arch Otolaryngol; 1985 May; 111(5):298-300. PubMed ID: 3985850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of lidocaine after intramuscular injection in patients with acute myocardial infarction (author's transl)].
    Oltmanns D; Siegers CP
    Z Kardiol; 1979 Mar; 68(3):131-6. PubMed ID: 442753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of five commonly-available, lidocaine-containing topical anesthetics and their effect on serum levels of lidocaine and its metabolite monoethylglycinexylidide (MEGX).
    Oni G; Brown S; Kenkel J
    Aesthet Surg J; 2012 May; 32(4):495-503. PubMed ID: 22452841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of lidocaine by continuous infusion.
    Bassan MM; Weinstein SR; Mandel WJ
    Am Heart J; 1974 Mar; 87(3):302-3. PubMed ID: 4812367
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of lidocaine resistance in man using intermittent large-dose infusion techniques.
    Alderman EL; Kerber RE; Harrison DC
    Am J Cardiol; 1974 Sep; 34(3):342-9. PubMed ID: 4851926
    [No Abstract]   [Full Text] [Related]  

  • 31. [Serum concentration of lidocaine and its active metabolite monoethylglycinexylidine during fiberoptic bronchoscopy under local anesthesia].
    Milman N; Laub MS; Munch EP; Angelo HR
    Ugeskr Laeger; 1991 Mar; 153(13):932-5. PubMed ID: 2024301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma level of lidocaine following intraoperative bolus injection and infusion in heart failure].
    Biscoping J; von Bormann B; Boldt J; Kling D; Hempelmann G
    Anasth Intensivther Notfallmed; 1984 Oct; 19(5):250-2. PubMed ID: 6335002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between plasma lignocaine levels and induced haemodynamic changes.
    Binnion PF; Murtagh G; Pollock AM; Fletcher E
    Br Med J; 1969 Aug; 3(5667):390-2. PubMed ID: 5797780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of lidocaine after prolonged intravenous infusions in uncomplicated myocardial infarction.
    LeLorier J; Grenon D; Latour Y; Caillé G; Dumont G; Brosseau A; Solignac A
    Ann Intern Med; 1977 Dec; 87(6):700-2. PubMed ID: 931206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal lidocaine dosing in patients with myocardial infarction.
    Lopez LM; Mehta JL; Robinson JD; Roberts RJ
    Ther Drug Monit; 1982; 4(3):271-6. PubMed ID: 6753254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lignocaine kinetics in cardiac patients and aged subjects.
    Nation RL; Triggs EJ; Selig M
    Br J Clin Pharmacol; 1977 Aug; 4(4):439-48. PubMed ID: 901735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of methods of lidocaine administration in patients.
    Salzer LB; Weinrib AB; Marina RJ; Lima JJ
    Clin Pharmacol Ther; 1981 May; 29(5):617-24. PubMed ID: 7214792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the duration of infusion on the disposition of lidocaine in dogs.
    LeLorier J; Moisan R; Gagné J; Caillé G
    J Pharmacol Exp Ther; 1977 Dec; 203(3):507-11. PubMed ID: 925956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observations on intravenous administration of lignocaine in patients with myocardial infarction.
    Campbell NP; Kelly JG; Adgey AA; McDevitt DG; Pantridge JF
    Br Heart J; 1978 Dec; 40(12):1371-5. PubMed ID: 737094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.